1338 (1338) Fair Value & Analysis

Consumer Defensive · Market cap HK$94.9M

1 1338 1338 · HK

PriceHK$0.0300

Fair ValueHK$0.0330

Upside+10.0%

Quality51/100

Watch 1338 for free — get notified when fair value or trend changes. Watch for free

Evidence: High Range HK$0.0330 – HK$0.0330

Fair value as of: Jul 2, 2026

From 23 valuation models · updated today

Share price +7.1% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.0260 – HK$0.0570 · the HK$0.0300 price screens below the HK$0.0330 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1338 (1338) currently trades at HK$0.0300, while our model-based Fair Value estimate is HK$0.0330 — implying the stock looks roughly 10.0% undervalued today. We read business quality at 51/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

Over the trailing twelve months, 1338 generated revenue of HK$273M at a net margin of 1.4%. Revenue grew 6.9% year over year. It earns a return on equity of 2.6%. The balance sheet holds a net cash position of HK$66.2M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$273M

Revenue growth (YoY) +6.9%

Net margin 1.4%

Return on equity 2.6%

Free cash flow HK$2.2M FY2025

Operating margin 4.0%

More key figures

EPS growth (YoY) +25.8%

Net cash HK$66.2M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1338 reported revenue of HK$273M in FY2025 versus HK$274M in FY2021, a compound −0.0%/yr. Reported net income was HK$3.9M in FY2025.

Revenue −0.0%/yr

FY21 HK$274M

FY22 HK$246M

FY23 HK$238M

FY24 HK$253M

FY25 HK$273M

Net income

FY21 −HK$9.1M

FY22 −HK$19.3M

FY23 HK$13.6M

FY24 HK$6.6M

FY25 HK$3.9M

Is 1338 fairly valued? → Check now

Similar stocks

6 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
PG PG	2,590 MXN	1,415 MXN	-45%
The Procter & Gamble Company PGCO34	R$53.60	R$29.97	-44%
L'Oréal S.A LRLCF	$428.02	$273.79	-36%
Unilever PLC UNLYF	$59.34	$46.11	-22%
Colgate-Palmolive Company CPA	€79.16	€55.96	-29%
Hindustan Unilever Limited HINDUNILVR	₹2,122	₹677.55	-68%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1338 (1338) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.0330 versus a price of HK$0.0300 — about +10% (undervalued). Model-based estimate, not financial advice.

What is the fair value of 1338?

Our model-based fair value for 1338 is HK$0.0330 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.0300.

What is the quality score of 1338?

1338 has a Quality Score of 51/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1338 (1338)?

1338 reported trailing-twelve-month revenue of about HK$273M (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1338?

The net profit margin of 1338 is about 1.4%, meaning it keeps roughly 1.4% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.